COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
NANOBIOTIX annonce l'acceptation par l'Agence américaine du médicament, la FDA, d'un protocole pour une nouvelle étude randomisée de Phase 2 évaluant NBTXR3 pour les patients atteints d'un cancer du poumon de stade trois
Nanobiotix annonce l'acceptation par la FDA d'un protocole pour une nouvelle étude de phase 2 sur NBTXR3 pour le cancer du poumon de stade III -
-
-
-
COMMUNIQUÉ DE PRESSE
Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress
Protagonist Therapeutics to present rusfertide Phase 2 REVIVE study data at EHA Congress in Madrid. Study shows absence of QTc prolongation with rusfertide. Details on pipeline drugs and collaborations available on company's website -
-
COMMUNIQUÉ DE PRESSE
Hamilton Health Box Raises $10 Million in Series A Funding to Accelerate Rural Market Expansion
Hamilton Health Box secures $10M Series A funding to expand into rural America, addressing Health Professional Shortage Areas. The unique microclinic model offers affordable primary care services -
-
COMMUNIQUÉ DE PRESSE
Rockingham County selects Waga Energy to produce RNG at the Rockingham County Landfill
Rockingham County selects Waga Energy to produce RNG at the Rockingham County Landfill. Waga Energy to install an RNG production facility using WAGABOX technology, aiming to reduce environmental impact and generate new revenues
